Prevention of Restenosis Following Revascularization

Clinical trial NCT00518284 · TERMINATED

Trial details

NCT number: NCT00518284
Sponsor: Celgene Corporation
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Vascular Disease, Peripheral

Start date: 2008-01-01
Primary completion: 2009-08-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.